TruthArchive.ai - Related Video Feed

Chronic hyperinsulinemia can lead to hypertension, a modifiable risk factor for dementia. Elevated insulin levels cause the kidneys to retain sodium, raising blood pressure. A low-carb diet can significantly reduce insulin secretion. Insulin is essential for glucose metabolism, but chronic elevation prevents fat utilization, which is crucial for brain energy. Vascular health is vital for cognitive function, as vascular dementia is common. Consuming carbohydrates in concentrated meals rather than spreading them throughout the day may reduce insulin secretion, especially for those with insulin resistance. Regular health screenings, including fasting blood glucose and insulin tests, are recommended to monitor metabolic health. The HOMA-IR calculation can assess insulin sensitivity, which is linked to brain energy production. Genetic factors, such as the APOE4 allele, can affect glucose metabolism and increase dementia risk. Amyloid plaques and tau tangles are associated with Alzheimer's disease, but their presence alone does not determine causation. Neuroinflammation and sleep are critical for brain health, as sleep helps clear amyloid from the brain. Diet plays a significant role; ultra-processed foods contribute to obesity and nutrient deficiencies. Avoid refined grains and seed oils, which spike blood sugar levels. Incorporating healthy fats with vegetables enhances nutrient absorption. Regular sauna use and stress management techniques can improve overall health and resilience.

In this podcast episode, Peter Attia and Tom Dayspring discuss atherosclerotic cardiovascular disease (ASCVD), the leading cause of death globally. They begin by outlining key risk factors, including age, smoking, lipid disorders, and high blood pressure. Dayspring emphasizes the importance of measuring ApoB and triglycerides in assessing cardiovascular risk, stating that ApoB is crucial for understanding lipid-related diseases. The conversation delves into the pathophysiology of atherosclerosis, explaining how cholesterol deposits in artery walls lead to plaque formation, which can cause heart attacks or strokes. They highlight that atherosclerosis is a slow process that can begin in childhood, with fatty streaks found in young children. Dayspring notes that most heart attacks occur in individuals over 40, but significant risk factors can develop much earlier. Dayspring explains the difference between causal risk factors (like smoking and high blood pressure) and risk markers (like coronary calcium scores and inflammatory markers). He stresses that while age and genetics are non-modifiable risk factors, lifestyle changes can significantly impact lipid levels and overall cardiovascular health. The discussion shifts to the role of ApoB, which is a marker for the number of atherogenic particles in the bloodstream. Dayspring explains that each ApoB particle corresponds to a lipoprotein that can enter the artery wall and contribute to atherosclerosis. They also discuss the implications of high triglycerides, which can lead to increased ApoB levels and a higher risk of cardiovascular events. Attia and Dayspring touch on the importance of HDL cholesterol, noting that its protective effects are not solely determined by its levels in the blood. They emphasize that HDL functionality is crucial and that high HDL levels do not guarantee cardiovascular protection. The podcast also explores the relationship between cholesterol and brain health. Dayspring explains that cholesterol is vital for brain function, with the brain synthesizing its own cholesterol rather than relying on peripheral sources. They discuss the role of ApoE in transporting cholesterol within the brain and its implications for Alzheimer's disease risk, particularly in individuals with the ApoE4 genotype. Finally, they highlight the advancements in lipid-lowering therapies, including statins and newer medications, and the importance of personalized treatment approaches. Dayspring expresses optimism about future developments in cardiovascular medicine, particularly regarding the understanding of ApoB and the potential for improved diagnostic tools. Overall, the episode provides a comprehensive overview of ASCVD, the role of lipids in cardiovascular and brain health, and the importance of personalized approaches to prevention and treatment.

Metabolic health is crucial for achieving true longevity and healthspan. It involves the body's ability to efficiently convert calories into energy and necessary building blocks, relying on optimal insulin sensitivity and metabolic pathways. Unfortunately, data from 2018 indicates that 93-94% of U.S. adults are metabolically unhealthy, leading to issues such as high blood sugar, which can cause cellular damage and contribute to diseases like cardiovascular disease and cancer. Metabolic dysfunction can lead to severe health consequences, including fatty liver disease, type 2 diabetes, and dementia. The pandemic highlighted the metabolic crisis, with many individuals unaware of their dysfunction. Lifestyle interventions, such as strength training and proper nutrition, are essential for improving metabolic health. Many people mistakenly focus solely on weight loss through medications like GLP-1 without addressing underlying metabolic issues. GLP-1 medications can aid in metabolic healing, improving insulin sensitivity, but they should not replace lifestyle changes. Individuals often need guidance to optimize their metabolic health while using these medications. Key indicators of metabolic health include waist circumference, blood pressure, and strength training frequency. Elevated waist circumference and blood pressure often correlate with poor metabolic health. To assess metabolic health, individuals can measure waist circumference against their height, monitor blood pressure, and ensure regular strength training. Fasting glucose levels and A1C tests provide insights into blood sugar control, while fasting insulin levels can indicate insulin sensitivity. Inflammation markers like high-sensitivity C-reactive protein and sedimentation rate are also important. Diet plays a significant role in metabolic health. Emphasizing adequate protein intake, particularly from animal sources, is crucial. Cooking vegetables can improve digestibility, and individuals should focus on whole foods while minimizing processed options. Community support and social connections can enhance health outcomes, as social environments influence individual health behaviors. In summary, achieving metabolic health requires a multifaceted approach, including lifestyle changes, dietary adjustments, and possibly medical interventions. Individuals should prioritize strength training, proper nutrition, and community support to foster long-term health and well-being.

Dr. Dhru Purohit and Dr. Jeremy London discuss how lifestyle factors influence cardiovascular disease, emphasizing how everyday choices accumulate risk. The conversation weaves through practical daily habits, from morning routines to evening patterns, illustrating how oral health, diet, physical activity, stress management, sleep hygiene, and social connection can accelerate or mitigate heart disease risk. London explains that poor oral health and the use of alcohol-based mouthwash can disrupt the oral microbiome and nitric oxide pathways, contributing to higher blood pressure and vascular injury. The hosts then dissect a typical day: loading up on ultra-processed, high-fat, high-sugar meals; prolonged sedentary work; and neglect of movement, all of which drive inflammatory states and blood sugar dysregulation. They stress that chronic hyperglycemia damages the endothelium, promotes plaque formation, and increases visceral fat, underscoring the interconnection between glucose control and cardiovascular health. The dialogue shifts to sleep and stress, highlighting how recovery, community, and downtime modulate autonomic balance and blood pressure, with cites to long-running Harvard studies on relationships and longevity. London emphasizes sleep as a critical repair window and shares personal experiences about sleep optimization tools and mindfulness strategies, including temperature regulation, saunas, and tracking devices that illuminate individual patterns without fostering anxiety. The discussion then ventures into objective measures, detailing lipid and metabolic panels, including LDL cholesterol, triglycerides, ApoB, and lipoprotein(a), and how these markers, along with HbA1c and fasting insulin, map onto heart disease risk. London recounts his own near-fatal event, describing how stress, early symptoms, and a delayed response converged to a critical moment, and how a successful intervention reshaped his priorities toward family, relationships, and prevention education. He calls for proactive screening, transparent discussion of test results, and personalized management—recognizing that genetics load the gun but lifestyle pulls the trigger. The episode closes with actionable guidance for at-home emergency response, the potential trade-offs of alcohol and dietary choices, and a forward-looking stance on sharing science-based, accessible health advice to empower listeners to act before a crisis occurs.

Peter Attia hosts Ethan Weiss for a discussion on various cardiovascular health topics, focusing on calcium scoring, CT angiograms, and the implications of metabolic health on heart disease. Ethan shares his recent career shift from academia to biotech, where he is involved in developing new companies. They begin by explaining calcium scores, which indicate the amount of calcium in coronary arteries and correlate with cardiovascular risk. A higher calcium score suggests a greater likelihood of heart disease, while a score of zero can provide reassurance, though its interpretation varies with age and risk factors. Ethan recounts his personal experience with calcium scoring, noting how his scores changed over time and the importance of CT angiograms for a more detailed assessment of coronary health. They discuss the limitations of calcium scans, particularly in younger patients, and the potential for false negatives. The conversation shifts to the differences between calcium scans and CT angiograms, emphasizing the latter's ability to provide more detailed information about plaque characteristics and overall cardiovascular risk. They explore the challenges of healthcare costs and insurance coverage for these tests, highlighting the disparities in pricing across facilities. Peter and Ethan agree on the necessity of aggressive treatment for patients with significant plaque burden, regardless of symptoms, and the importance of managing risk factors like LDL cholesterol and blood pressure. The discussion then turns to blood pressure management, with Peter emphasizing the need for awareness and treatment of hypertension as a critical public health issue. They reflect on the SPRINT trial, which demonstrated the benefits of lowering blood pressure to 120/80 mmHg, and the implications of this for clinical practice. They also touch on the complexities of individual responses to blood pressure medications and the importance of tailoring treatment to patient needs. Ethan highlights the significance of metabolic health, particularly the distribution of body fat, in assessing cardiovascular risk. They discuss the concept of lipodystrophy and its association with increased risk of heart disease, emphasizing the need for further research into the genetic factors that contribute to these conditions. Overall, the conversation underscores the importance of proactive cardiovascular health management, the need for better tools to assess risk, and the potential for new therapies to address metabolic issues related to heart disease.

Alzheimer's disease is projected to affect 45 million Americans, with lifestyle factors like diet and insulin resistance playing critical roles in brain health. The Western diet accelerates brain aging, while fasting can help reverse these conditions. Insulin resistance occurs when the body struggles to manage glucose, leading to various metabolic issues. This condition can manifest years before glucose levels rise, making it essential to monitor waist circumference and lipid panels as early indicators. The link between insulin resistance and Alzheimer's is significant; elevated glucose and insulin levels can hinder the brain's ability to clear amyloid plaques, which are associated with Alzheimer's. Chronic inflammation and insulin resistance create a perfect storm for neurodegenerative diseases. To reduce Alzheimer's risk, individuals should evaluate their lifestyle and health metrics, focusing on triglyceride levels, HDL cholesterol, liver function tests, and inflammation markers. Dietary habits, particularly carbohydrate intake, are crucial in managing insulin resistance. Many people, especially those from South Asian backgrounds, may consume healthy foods that still contribute to insulin resistance due to high carbohydrate content. The concept of "skinny fat" highlights that individuals can appear thin yet have high visceral fat, which is more harmful than subcutaneous fat. This phenomenon is particularly prevalent in certain ethnic groups, where even small amounts of excess weight can lead to significant metabolic issues. The discussion emphasizes the importance of personalized nutrition and exercise, as well as the need for awareness about the impact of modern diets and sedentary lifestyles on health. Fasting and meal sequencing can help manage blood sugar levels, and incorporating more vegetables and healthy fats into meals can mitigate the effects of carbohydrates. Women are disproportionately affected by Alzheimer's, with hormonal changes during menopause contributing to cognitive decline. Estradiol, a key hormone, supports brain health, and its decline can lead to increased risk for Alzheimer's. Understanding these changes is vital for prevention, and early intervention can significantly impact long-term health outcomes. The conversation also touches on the importance of addressing environmental toxins, such as heavy metals and mold, which can contribute to cognitive decline. Regular monitoring and proactive health measures, including brain scans and lifestyle modifications, are essential for reducing the risk of Alzheimer's and other neurodegenerative diseases. Overall, the key takeaways include the importance of diet, exercise, hormonal health, and environmental factors in maintaining cognitive function and preventing Alzheimer's disease. Individuals are encouraged to take proactive steps in their health journey, focusing on personalized strategies that align with their unique needs and backgrounds.

Eighty-eight percent of American adults have at least one biomarker of metabolic dysfunction, highlighting the importance of understanding metabolic health through lab tests. Casey Means emphasizes the need for optimal lab ranges, particularly focusing on three critical tests: the triglyceride to HDL ratio, fasting insulin, and hemoglobin A1c. The triglyceride to HDL ratio serves as a surrogate marker for insulin resistance, yet many doctors overlook it. Fasting insulin is crucial as it can indicate metabolic dysfunction long before glucose levels change, while hemoglobin A1c provides a three-month average of glucose levels, though it has limitations regarding daily variability. Metabolic health is defined as how effectively our bodies generate energy, and current dietary habits in the U.S. are contributing to a crisis in energy processing. Elevated blood glucose levels are linked to numerous health risks, including type 2 diabetes, heart disease, and Alzheimer's. With 128 million Americans experiencing glucose dysregulation, understanding glucose and its metabolic context is vital. Means discusses the importance of lab tests in understanding energy processing, including cholesterol panels and inflammatory markers like CRP. Many people receive a “normal” label from doctors without deeper analysis, which can lead to missed opportunities for early intervention. The conversation encourages individuals to take charge of their health by understanding lab results and making lifestyle changes to improve metabolic health. The discussion also touches on the limited education doctors receive regarding nutrition and metabolic health, leading to a focus on medications rather than lifestyle interventions. Means advocates for patients to be proactive in their health management, using lab tests as tools for personal insight and empowerment. Key lab tests include: - **Triglyceride to HDL Ratio**: Aim for less than 2.5 for Caucasians and less than 1.5 for African Americans, ideally closer to 1. - **Fasting Insulin**: Less than 10 is optimal, with many experts suggesting 2-6. - **Hemoglobin A1c**: Aim for below 5.5% for optimal glucose control. Means emphasizes that lifestyle changes can significantly impact these markers, and individuals should view their health data as a narrative to guide their choices. The Levels membership offers access to a metabolic health panel, allowing users to track their health metrics conveniently. The overarching message is to take ownership of health decisions, using data to inform dietary and lifestyle choices for better overall well-being.

In this episode of The Peter Attia Drive, host Peter Attia and guest Dr. Thomas Dayspring delve into lipidology, discussing various biomarkers related to cardiovascular health, including LP(a), inflammation, oxidized LDL, and other lipid particles. They emphasize the significance of understanding LP(a) and its clearance mechanisms, particularly the role of LDL receptors. Dayspring explains that LP(a) is an LDL-like particle with an additional protein, apolipoprotein(a), which complicates its clearance by the liver. The conversation touches on the limitations of measuring LP(a) mass and the importance of distinguishing between particle counts and mass measurements. They discuss the challenges of using niacin and statins to lower LP(a) levels, noting that while niacin can reduce LP(a), statins do not affect it significantly. Dayspring highlights the need for better therapeutic options, such as PCSK9 inhibitors and potential future drugs targeting apolipoprotein(a) synthesis. The hosts also explore the role of inflammation in cardiovascular disease, mentioning ongoing trials involving anti-inflammatory drugs like low-dose methotrexate and IL-1 inhibitors. They discuss various biomarkers for endothelial dysfunction and oxidative stress, including myeloperoxidase and F2-isoprostanes, and their implications for cardiovascular risk assessment. Dayspring shares a personal story about a close friend who died from a heart attack, underscoring the importance of early detection and treatment of lipid disorders. The episode concludes with a call to action for clinicians to educate themselves on lipidology and the complexities of cardiovascular disease, emphasizing the need for personalized approaches to treatment based on individual risk factors and biomarkers.

The episode centers on proactive health screening and risk assessment for the major diseases of aging, with a focus on cardiovascular disease, cancer, and neurodegenerative conditions. Dr. Eric Topol explains that many chronic diseases incubate for years before clinical signs appear, creating a window for prevention through smarter testing beyond traditional risk factors like smoking or high LDL. A key topic is the polygenic risk score, a low-cost saliva-based test that aggregates thousands of genetic variants to estimate a person’s lifetime risk of heart disease, cancer, and Alzheimer's. Topol emphasizes that while such scores do not measure current disease burden, they can reveal hidden risk and help tailor preventive actions, though the data should be interpreted in context and not as a sole determinant of care. He notes that emerging approaches, such as artery and heart aging clocks and proteomic organ clocks, promise to provide a dynamic view of biological aging and organ-specific risk, but these tools require independent replication and careful integration into clinical practice. The conversation also addresses limitations and potential harms of testing, including the psychological impact of calcium scans and the risk of incidental findings leading to unnecessary procedures. In the cancer discussion, the guests explore the balance between early detection and overtesting, highlighting the added value of AI-assisted mammography and the judicious use of polygenic scores and broader genomic testing to guide screening intervals and preventive strategies. The Alzheimer’s section spotlights PTA 217, a blood biomarker that can detect preclinical disease years before symptoms and might be modifiable through exercise and lifestyle. Throughout, Topol advocates for patient empowerment, informed consent, and a cautious approach to new tests, warning against hype around total-body MRIs and emphasizing that prevention should rely on robust evidence, cost-effectiveness, and real-world impact. The exchange also covers practical lifestyle factors, including exercise, sleep regularity, air quality, diet, and emerging gut-hormone therapies, framing them as meaningful levers that may slow age-related disease processes when applied thoughtfully. The overall message is one of balanced optimism: we have powerful new tools on the horizon, but their clinical adoption should be measured, replicated, and oriented toward tangible improvements in health and longevity.

Dr. Joel Kahn discusses heart health assessments, emphasizing that feeling good is not enough to ensure a healthy heart. He recommends a coronary artery calcium CT scan, ideally aiming for a score of zero, which indicates no calcified plaque. If the score is not zero, lifestyle changes are necessary. For a more comprehensive view, a CT angiogram can be performed, though it is not the first test to consider. Kahn highlights the importance of blood tests, particularly hemoglobin A1c for blood sugar levels, fasting insulin, hsCRP for inflammation, and lipoprotein little a (LP(a)), a genetic cholesterol that can be harmful. He also mentions APO lipoprotein B (APO B), which aggregates all bad cholesterol particles into one number, helping to assess cardiovascular risk. He stresses the significance of lifestyle factors such as diet, sleep, and exercise in managing heart health. Kahn advocates for a whole food, plant-based diet, while acknowledging that individuals can have varying dietary needs. He notes that high LDL cholesterol levels can exist alongside good metabolic health, underscoring the need for personalized assessments. Kahn also discusses the role of supplements, particularly aged garlic extract and a product called Arterial Protect, which contains Gotu Kola and Pycnogenol, both shown to reduce plaque. He cautions against high doses of vitamin K2, as recent studies show no significant impact on calcium scores. The conversation touches on the importance of strength training and adequate protein intake for muscle mass and metabolic health. Kahn references Dr. Walter Longo's research advocating for lower protein intake for longevity, suggesting a balanced approach to diet and exercise. Finally, Kahn emphasizes the need for proactive heart disease screening, particularly for high-risk populations like South Asians, and encourages individuals to seek personalized medical advice to ensure optimal heart health.

A recent study found that individuals with microplastics in their blood vessels are 4.53 times more likely to experience heart attacks, strokes, or death within three years. The study analyzed plaque from 257 patients undergoing carotid endarterectomy, revealing detectable levels of polyethylene in about 50% of the samples. The presence of microplastics in the immune system's macrophages caused oxidative stress and inflammation, raising concerns about their impact on vascular health. Experts suggest that while completely eliminating microplastics is unrealistic, individuals can take steps to protect themselves. Drinking filtered water, preferably from reverse osmosis systems, and being mindful of air quality, especially during sleep, are recommended. Vascular health is crucial for longevity, and many heart attacks are preventable through early lifestyle interventions focusing on endothelial health and risk factors like high blood pressure, dyslipidemia, diabetes, smoking, and obesity. The endothelium, a one-cell-thick lining of arteries, plays a critical role in vascular health. Impaired endothelium can lead to inflammation and plaque formation. Precision cardiology is emerging as a field that emphasizes individualized care, focusing on the health of arteries rather than just treating symptoms. Cardiovascular disease remains the leading cause of death globally, with over 800,000 heart attacks occurring annually in the U.S. Many heart attacks could be prevented with early interventions. Standard advice includes monitoring lipid panels, blood pressure, A1C levels, and lifestyle factors like exercise. However, numerous other risk factors can affect vascular health. The endothelial glycocalyx, a protective gel coating on arteries, is crucial for preventing plaque formation. Factors like smoking, high insulin levels, air pollution, and microplastics can damage the glycocalyx, leading to increased risk of cardiovascular disease. Repairing the glycocalyx involves lifestyle changes, such as increasing physical activity and consuming green leafy vegetables. Metabolic health is gaining attention, with a focus on pre-diabetes and blood sugar management. Building resilience against environmental toxins and promoting cardiovascular health through exercise and resistance training are essential. Nitric oxide, a vasodilator produced by healthy endothelium, is vital for maintaining normal blood flow and preventing plaque buildup. The podcast emphasizes the importance of personalized dietary approaches to heart health. While various diets can be beneficial, individual responses vary based on genetics and metabolic health. Recommendations include consuming a Mediterranean-style diet, avoiding ultra-processed foods, and ensuring adequate intake of omega-3 fatty acids. Supplementation may be necessary for individuals not meeting dietary needs. Nitric oxide boosters, omega-3 supplements, and specific products like Arterosil and Kyolic garlic can support vascular health and potentially reduce plaque buildup. Statins remain a common pharmaceutical intervention, though their use should be tailored to individual patient needs and genetic factors. The Clearly test, which assesses plaque volume in arteries, is highlighted as a sensitive diagnostic tool for predicting cardiovascular risk. It can identify soft plaques that are more likely to rupture and cause heart attacks. The podcast concludes by emphasizing the importance of proactive health management, focusing on lifestyle changes, testing, and personalized interventions to improve vascular health and longevity.

Louisa Nicola discusses the rising rates of Alzheimer's and dementia, emphasizing that these conditions often begin silently in the brain decades before symptoms appear. Currently, around 50 million people worldwide have dementia, with projections suggesting this number could triple by 2050, posing a significant economic burden on healthcare systems. Nicola highlights that Alzheimer's is not solely genetically determined, as many people with risk genes may never develop the disease. She explains the role of amyloid and tau proteins, noting that while they are associated with Alzheimer's, they may not be the primary instigators of the disease. Nicola stresses the importance of lifestyle choices in reducing Alzheimer's risk, particularly for women, who are disproportionately affected. She advocates for hormone replacement therapy (HRT) during menopause, which can protect brain health. Regular exercise, especially resistance training, is crucial for maintaining cognitive function and overall health. Studies show a direct correlation between muscle mass and brain volume, suggesting that strength training can enhance cognitive abilities. Nutrition also plays a vital role in brain health. Nicola promotes the consumption of omega-3 fatty acids, particularly from fatty fish like sardines, which are beneficial for cognitive function. She discusses the importance of maintaining a healthy omega-3 index and the potential risks associated with unregulated supplements. Finally, Nicola mentions emerging blood tests that can detect amyloid and tau proteins, offering a less invasive alternative to traditional diagnostic methods. She encourages proactive health management and emphasizes the need for a balanced approach to exercise and nutrition to support brain health and longevity.

In the realm of cardiology, several myths persist regarding cardiovascular disease. One major misconception is that normal EKG and stress test results indicate low heart disease risk. However, these tests do not assess atherosclerosis, which can develop silently, often without symptoms until a heart attack occurs. Another myth is the oversimplification of cholesterol's role in heart disease. While cholesterol is essential for bodily functions, its transport in lipoproteins is more critical than the cholesterol levels themselves. Traditional cholesterol panels provide a crude estimate of cardiovascular health, missing nuances like particle size and number. Commonly recognized risk factors for cardiovascular disease include hypertension, dyslipidemia, diabetes, and obesity. However, there are nearly 400 other risk factors that can contribute to atherosclerosis, emphasizing the need for advanced testing beyond the basic five. For instance, blood pressure measurements often lack accuracy due to rushed assessments in clinical settings. More precise methods, such as central blood pressure assessments, can provide better insights. The conversation also highlights the importance of endothelial health, particularly nitric oxide production, which is crucial for maintaining vascular function. Factors such as high blood sugar, stress, and inflammation can damage the endothelium, leading to plaque formation. Lifestyle factors, including diet, stress management, and sleep quality, significantly influence cardiovascular health. Stress management techniques, such as meditation and deep breathing, can enhance heart rate variability, indicating better stress resilience. Emerging technologies like the Cleerly scan utilize AI to analyze plaque characteristics in arteries, offering insights beyond traditional imaging methods. This test can identify soft plaque, which poses a higher risk for cardiovascular events. The Cleerly scan is particularly valuable for assessing individuals with elevated lipoprotein levels, guiding treatment decisions. Overall, the discussion emphasizes the need for personalized medicine in cardiovascular health, advocating for comprehensive testing and lifestyle modifications to optimize heart health. The importance of understanding individual risk factors and the interplay of lifestyle choices in managing cardiovascular disease is underscored, promoting a holistic approach to prevention and treatment.

Peter Attia and Benoît Arsenault discuss the significance of lipoprotein(a) or Lp(a) in cardiovascular health, a topic that has gained traction over the past decade. Arsenault's interest in Lp(a) began during his postdoctoral research, where he found that Lp(a) was a strong predictor of residual cardiovascular risk, particularly in studies involving genetic associations. He highlights that about 20% of the global population has elevated Lp(a) levels, which vary by ethnicity, with individuals of African descent showing the highest levels. Historically, Lp(a) was overlooked due to negative studies in the 1990s and early 2000s, primarily due to poor assay methods. However, advancements in genetic studies have revived interest, demonstrating that genetic variants associated with high Lp(a) levels correlate with increased cardiovascular events. Attia emphasizes the importance of understanding the relationship between Lp(a) and LDL cholesterol, noting that Lp(a) is a modified form of LDL that carries additional risks. The conversation shifts to the complexities of measuring Lp(a), with Arsenault advocating for measurements in nanomoles per liter rather than milligrams per deciliter to better assess cardiovascular risk. They discuss the production of Lp(a) in the liver and its unique structure, which includes variations in apolipoprotein(a) isoform sizes that contribute to its pathogenicity. Attia and Arsenault explore the role of Lp(a) in atherosclerosis, noting that it may not initiate plaque formation but can exacerbate existing conditions. They discuss the association of Lp(a) with various cardiovascular diseases, including myocardial infarction, aortic stenosis, and peripheral artery disease, while emphasizing the need for better awareness among healthcare providers. The discussion also covers treatment options, including statins, which do not effectively lower Lp(a) levels, and the potential of PCSK9 inhibitors to reduce Lp(a) by about 30%. They highlight ongoing research into antisense oligonucleotides targeting Lp(a), which show promise in significantly lowering its levels and potentially improving cardiovascular outcomes. Arsenault concludes by stressing the importance of measuring Lp(a) in patients, particularly those with a family history of cardiovascular disease, and the need for further research to understand the full implications of elevated Lp(a) levels. Attia encourages listeners to advocate for Lp(a) testing and to manage other cardiovascular risk factors proactively.